Westlake Chemical (NYSE: WLK) reported Q2 EPS of $0.85, $0.11 worse than the analyst estimate of $0.96. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.06 billion.

For earnings history and earnings-related data on Westlake Chemical (WLK) click here.